Treatment Analysis Respiratory Physical Therapy on SARS-COV-2

Abstract

SARS-CoV-2 is a member of a large family of viruses called coronaviruses. This specific virus can infect human and some animals. SARS-CoV-2 was first known to infect people in 2019. The virus is thought to spread from person to person through droplets released when an infected person coughs, sneezes, or talks. It may also be spread by touching a surface with the virus on it and then touching one’s mouth, nose, or eyes, but this is less common. Research is being done to treat COVID-19 and to prevent infection with SARS-CoV-2. Also called severe acute respiratory syndrome coronavirus 2. Coronavirus disease 2019, SARS-CO V-2 is the 3rd coronavirus infectious disease happening in 20 years was initially defined in Asia, later Middle East Respiratory Syndrome (MERS), & severe acute respiratory syndrome (SARS). SARS-CO V-2 illness expands globally, intensive care unit (ICU) specialists, health care management, authority, plan creators, and researchers need to brace for sudden increase of high volume in critical patients. Physiotherapists (PTs), mostly respiratory PTs, are healthcare specialists involved in managing and caring for the population of these patients, & play important part in conservative care and treatment, changes in posture, functional mobility and while invasive mechanical ventilator support is being weaned. The objective of the study is to identify treatment analysis recent research evidences for the management of physiotherapist during SARS-CO V-2 pandemic. This study provides a quick respiratory physiotherapist reference guide to set up treatments for the management in acute stages of patients suffering from severe SARS-COV-2.